Ann: RAP Licenses Additional Pneumonia Diagnostic from UniQuest, page-171

I feel many are underestimating the commercialisation / integration risk that this tech may have. Integrating in to a major telehealth / insurance company may take many months of trials & coding of APIs etc to get it right. (I'm not saying it WILL - I'm saying it MAY)

All the while, there will be no revenue flowing through the door & the quarterly burn is c. $2.5m

A good comparison (from an integration perspective) may be to CR8. They're trying to integrate their AI in to the largest insurance company in the US & its taking much longer than anticipated & the SP has been smashed from 10c to 3c as the insurance company's security requirements are extremely onerous.

The comparison is apt given both companies are trying to integrate with insurers in the states & both have digital solutions.

The telehealth / insurers will want to ensure there is absolutely zero litigation risk for themselves given the US is the most litigious jurisdiction in the world.

I don't for a second doubt the results from the upcoming US trials will be nothing less than spectacular - however that wont mean immediate $ flowing through the door & all the while they're burning c. $2.5m/Qtr

Worthy of a consideration at least.